🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
ABB
$ABBV
🔒 US EquitiesAbbVie Inc.
AVG HISTORICAL GAP
-1.09%
MAX GAP RECORD
-10.49%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $ABBV
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$ABBV
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 30, 2026 Earnings Release 2026-10-30 (BEFORE OPEN (08:00)) |
+0.00%
|
| Jul 31, 2026 Earnings Release 2026-07-31 (BEFORE OPEN) |
-1.89%
|
| May 01, 2026 Earnings Release 2026-05-01 (AFTER CLOSE) |
-0.68%
|
| Feb 04, 2026 Earnings Release 2026-02-04 (BEFORE OPEN) |
-7.04%
|
| Oct 31, 2025 Earnings Release 2025-10-31 (BEFORE OPEN) |
-2.28%
|
| Jul 25, 2025 Earnings Release 2025-07-25 (BEFORE OPEN) |
+0.04%
|
| Apr 25, 2025 Earnings Release 2025-04-25 (BEFORE OPEN) |
+3.74%
|
| Jan 31, 2025 Earnings Release 2025-01-31 (BEFORE OPEN) |
+6.63%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.2%
Bullish Gaps (5)
Bearish Gaps (6)
Neutral / Flat (4)
📖 Intelligence Summary
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗